Back

RT @MPishvaian
#TumorBoardTuesday #GI23
The last trial that I wasfor was dabrafenib, trametinib, irinotecan and cetuximab in BRAF V600E-mut mCRCby Chen, et al
Thisdrug combo only resulted in a mPFS of 7.5 mos, and ORR of 30% - which is very similar to encorafenib + cetux alone